BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 4, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 1, 2008
View Archived Issues
BMS After ImClone; Offers $60 per Share for Erbitux Partner
On the heels of Roche Holdings AG's $44 billion offer for Genentech Inc., as potentially the biggest buyout bid in the industry, another big pharma has made a play for its biotech collaborator. (BioWorld Today)
Read More
No New Trials Needed for Cadence's Acetavance
Read More
iPS Cells from ALS Patients May Help Research, Therapy
Read More
FDA Restrictions on ESAs Bring Wall Street Yawns
Read More
Genmab, GSK CLL Drug Sails Through Pivotal Test
Read More
NewCo News: Sierra Raises $21.5M to Boost its CNS Drug Delivery Mode
Read More
AtheroGenics Riding High in Positive Diabetes Trial
Read More
Other News To Note
Read More
Clinic Roundup
Read More
U.S. Patent Disclosures
Read More